» Articles » PMID: 32737331

Cleavage of Proteoglycans, Plasma Proteins and the Platelet-derived Growth Factor Receptor in the Hemorrhagic Process Induced by Snake Venom Metalloproteinases

Overview
Journal Sci Rep
Specialty Science
Date 2020 Aug 2
PMID 32737331
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Envenoming by viperid snakes results in a complex pattern of tissue damage, including hemorrhage, which in severe cases may lead to permanent sequelae. Snake venom metalloproteinases (SVMPs) are main players in this pathogenesis, acting synergistically upon different mammalian proteomes. Hemorrhagic Factor 3 (HF3), a P-III class SVMP from Bothrops jararaca, induces severe local hemorrhage at pmol doses in a murine model. Our hypothesis is that in a complex scenario of tissue damage, HF3 triggers proteolytic cascades by acting on a partially known substrate repertoire. Here, we focused on the hypothesis that different proteoglycans, plasma proteins, and the platelet derived growth factor receptor (PDGFR) could be involved in the HF3-induced hemorrhagic process. In surface plasmon resonance assays, various proteoglycans were demonstrated to interact with HF3, and their incubation with HF3 showed degradation or limited proteolysis. Likewise, Western blot analysis showed in vivo degradation of biglycan, decorin, glypican, lumican and syndecan in the HF3-induced hemorrhagic process. Moreover, antithrombin III, complement components C3 and C4, factor II and plasminogen were cleaved in vitro by HF3. Notably, HF3 cleaved PDGFR (alpha and beta) and PDGF in vitro, while both receptor forms were detected as cleaved in vivo in the hemorrhagic process induced by HF3. These findings outline the multifactorial character of SVMP-induced tissue damage, including the transient activation of tissue proteinases, and underscore for the first time that endothelial glycocalyx proteoglycans and PDGFR are targets of SVMPs in the disruption of microvasculature integrity and generation of hemorrhage.

Citing Articles

Importance of the Cysteine-Rich Domain of Snake Venom Prothrombin Activators: Insights Gained from Synthetic Neutralizing Antibodies.

Misson Mindrebo L, Mindrebo J, Tran Q, Wilkinson M, Smith J, Verma M Toxins (Basel). 2024; 16(8).

PMID: 39195771 PMC: 11360484. DOI: 10.3390/toxins16080361.


Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system.

Zhong X, Wang C, Li Y, Zhang Q, Sun Q Heliyon. 2024; 10(10):e30969.

PMID: 38813202 PMC: 11133756. DOI: 10.1016/j.heliyon.2024.e30969.


A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer's disease.

Tsartsalis S, Sleven H, Fancy N, Wessely F, Smith A, Willumsen N Nat Commun. 2024; 15(1):2243.

PMID: 38472200 PMC: 10933340. DOI: 10.1038/s41467-024-46630-z.


Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors.

Clare R, Dawson C, Westhorpe A, Albulescu L, Woodley C, Mosallam N Front Pharmacol. 2024; 14:1328950.

PMID: 38273820 PMC: 10808794. DOI: 10.3389/fphar.2023.1328950.


Biochemical and hemostatic description of a thrombin-like enzyme TLBro from snake venom.

Vilca-Quispe A, Alvarez-Risco A, Gomes Heleno M, Ponce-Fuentes E, Vera-Gonzales C, Zegarra-Aragon H Front Chem. 2023; 11:1217329.

PMID: 38099189 PMC: 10720248. DOI: 10.3389/fchem.2023.1217329.


References
1.
Fox J, Serrano S . Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity. FEBS J. 2008; 275(12):3016-30. DOI: 10.1111/j.1742-4658.2008.06466.x. View

2.
Oliveira A, Paes Leme A, Asega A, Camargo A, Fox J, Serrano S . New insights into the structural elements involved in the skin haemorrhage induced by snake venom metalloproteinases. Thromb Haemost. 2010; 104(3):485-97. DOI: 10.1160/TH09-12-0855. View

3.
Baldo C, Jamora C, Yamanouye N, Zorn T, Moura-da-Silva A . Mechanisms of vascular damage by hemorrhagic snake venom metalloproteinases: tissue distribution and in situ hydrolysis. PLoS Negl Trop Dis. 2010; 4(6):e727. PMC: 2894137. DOI: 10.1371/journal.pntd.0000727. View

4.
Moura-da-Silva A, Ramos O, Baldo C, Niland S, Hansen U, Ventura J . Collagen binding is a key factor for the hemorrhagic activity of snake venom metalloproteinases. Biochimie. 2007; 90(3):484-92. DOI: 10.1016/j.biochi.2007.11.009. View

5.
Serrano S, Kim J, Wang D, Dragulev B, Shannon J, Mann H . The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: role in substrate targeting. J Biol Chem. 2006; 281(52):39746-56. DOI: 10.1074/jbc.M604855200. View